Ionis Pharmaceuticals, Inc.
Modulators of PNPLA3 expression
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PNPLA3 expression, which may be useful for treating, preventing, or ameliorating a disease associated with PNPLA3.
Status:
Grant
Type:
Utility
Filling date:
18 Sep 2019
Issue date:
15 Sep 2020